What is CVE-2023-40276?

CVE-2023-40276 is a critical-severity vulnerability in Openclinic Ga Project, classified under Information Disclosure. CVSS score: 9.1/10. Published 2024-03-19.

How severe is CVE-2023-40276?

Critical severity. CVSS v3 base score is 9.1 out of 10.

Is CVE-2023-40276 known to be exploited?

4 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.

Information disclosure in Openclinic Ga Project

CVE-2023-40276

An issue was discovered in OpenClinic GA 5.247.01. An Unauthenticated File Download vulnerability has been discovered in pharmacy/exportFile.jsp.

Vulnerability class: Information Disclosure

EPSS: 0.007 (50.7th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 9.1 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N.

Affected products

Openclinic_ga_project Openclinic_ga — versions 5.247.01
N/a — versions n/a

Weakness classification (CWE)

CWE-200 — Information Disclosure

Public proof-of-concept exploits

References

cve@mitre.org (Product)
cve@mitre.org (Exploit, Third Party Advisory)

Frequently asked questions

What is CVE-2023-40276?: CVE-2023-40276 is a critical-severity vulnerability in Openclinic Ga Project, classified under Information Disclosure. CVSS score: 9.1/10. Published 2024-03-19.
How severe is CVE-2023-40276?: Critical severity. CVSS v3 base score is 9.1 out of 10.
Is CVE-2023-40276 known to be exploited?: 4 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.